We have developed a non-competitive sandwich enzyme-linked immunosorbent assay for the quantitation of apolipoprotein B, which utilizes the biotin-avidin amplification system. All components were optimized with respect to either concentration or incubation time. The assay uses microtitre wells as a solid phase and polyclonal, affinity-purified capture antibody. The amplification system was composed of hydroxysuccinimide biotin conjugated to an affinity-purified anti-apolipoprotein B IgG and either ExtrAvidin-alkaline phosphatase or streptavidin-alkaline phosphatase. The within-run precision (n = 10) of the apolipoprotein B control (1.39 g/1) was 3%, while the between-run precision of the assay (n = 6) for 9 consecutive assays was determined to be 8%. A sensitivity of 3 ng was attained, with a mean analytical recovery of 110%. Comparison of the assay with an established immunoturbidometric method resulted in a correlation of 0.92 using patient plasma samples (n = 19). The use of the biotin-avidin amplification system provides the sensitivity required for measuring apolipoprotein B in tissue culture media samples and circumvents the many problems associated with the direct conjugation of enzymes to antibodies. Minimal amounts of reagents are required and the assay can be performed in 5 h, making it both economical and practical for clinical laboratories.
A considerable number of methods have been utilized Apolipoprotein B is the major protein component of to quantitate plasma apolipoprotein B concentravery low density lipoprotein (VLDL) and low density tions. The majority of these assays are immunological lipoprotein (LDL) in humans. It is a structural protein techniques such as immunonephelometry (4, 5) , rathat allows lipids to be transported in the aqueous dioimmunoassay (RIA) (6, 7) and enzyme immunoplasma environment. In addition, apolipoprotein B assay (EIA) (8, 9) . While immunonephelometric asbinds to cell surface receptors and facilitates incor-says are fast and accurate, their sensitivity to the poration of lipoproteins into peripheral tissues and turbidity of the sample and the requirement of the organs. Increasing attention is being paid to deter-use of enzymes or detergents with hypertriglyceriminating apolipoprotein B concentrations in plasma, daemic samples are definite drawbacks (10) . RIAs due to evidence suggesting its usefulness in diagnosing developed for the determination of apolipoprotein B and characterizing various types of dyslipidaemias(l). concentrations show good accuracy and sensitivity, Measuring apolipoprotein B concentration may also but have several disadvantages, such as expensive be useful in determining the severity of coronary heart reagents and the use of radioisotopes (10, 11) . Quandisease (2) and in predicting the risk of its develop-titation of apolipoprotein B by El As such as enzymement (3) .
linked immunosorbent assay (ELISA) gives results that are reproducible, accurate, and with a sensitivity without interference from sample turbidity as in immunoturbidometric methods. A few direct ELISA assays have been developed for plasma apolipoprotein B determinations (12) (13) (14) (15) (16) . The major drawback with these assays is the direct conjugation of apolipoprotein B antibody to an enzyme using harsh crosslinkers such as glutaraldehyde or periodate which have a potential for causing changes in antibody-antigen binding, resulting in lower enzyme activity (17) .
We have developed a non-competitive sandwich ELISA for the measurement of apolipoprotein B concentrations utilizing the biotin-avidin amplification system. The use of the biotin-avidin system circumvents the above problem with enzyme-antibody conjugation by using a biotinylated antibody that can be prepared under mild and non-denaturing conditions. In addition, the assay uses minimal amounts of reagents and can be performed in a normal working day, making it both economical and practical for clinical laboratories. Further, the high sensitivity of the assay allows it to be applied to in vitro cell-culture studies where apolipoprotein B concentrations are extremely low.
by western-blotting of both plasma and media samples. The antibody was determined to be reactive with both apolipoprotein B-100 and apolipoprotein B-48. No cross-reactivity was observed between the antibody and other apolipoproteins based on immunoblotting of whole plasma'and HepG2 culture media (data not shown).
Apolipoprotein B antibody-biotin conjugate
The biotinylation of the apolipoprotein B antibody was conducted using a modification of a procedure by Bayer & Wilchek (18) . A solution of 0.5 mg apolipoprotein B antibody and 500 μΐ sodium borate buffer (0.1 mol/l pH 8.8) was prepared. The solution was diaiyzed for 16 h at 4 °C against the borate buffer to remove sodium azide. A solution of 1 mg N-hydroxysuccinimide biotin (Sigma Chemical Co., St. Louis MO) in 100 μΐ dimethyl sulphoxide was prepared. A total of 250 μ § of the biotin ester was added with continuous mixing to the antibody solution. Such a ratio of ester to antibody resulted in a high probability that all the antibodies were biotinylated. The solution was incubated for 2 h in the dark at room temperature. The antibody-biotin conjugate was then treated with 50 μΐ of 1 mol/l NH 4 C1 for 10 min at room temperature. The preparation was then diaiyzed against phosphate buffered saline for 36 h to remove unbound biotin. Following dialysis, the antibody-biotin conjugate was stored at 4 °C and was stable for 3 months. The biotinylation procedure resulted in a molar ratio of ester to antibody of more than 10:1. The antibody-biotin conjugate working solution was prepared by dilution in 10 mmol/1 Tris pH 7.8 containing 3 g/1 bovine serum albumin and 0.4 mol/l KC1.
Materials and Methods
Blood and media samples 
Apolipoprotein B standards and control
The apolipoprotein B standards and control (Atlantic Antibodies, Scarborough, Maine) were diluted in phosphate buffered saline containing 5 g/1 bovine serum albumin and 0.5 ml per litre Tween-20. The concentrations of the standards and control (Atlantic Antibodies) used in both the immunoturbidometric and ELISA methods were based on a CDC reference material (IUIS-WHO Apo-AI and B serum reference material) from the CDC, Atlanta GA. Both the ELISA and the immunoturbidometric assays were calibrated with the same standards, which were in turn standardized based on the CDC reference material. The accuracy of the two methods was further examined by running a commercial control material, the value of which was also assigned based on the CDC reference material.
Apolipoprotein B antibody
The apolipoprotein B antibody used in this assay was an affinity-purified IgG fraction obtained from Medix Biotech Inc, Foster City CA. This preparation was thoroughly characterized Coating procedure Microtitre 8 well strips (Costar, Cambridge MA) were coated with affinity-purified apolipoprotein B antibody that was diluted in 50 mmol/1 carbonate buffer, pH 9.6. A volume of 100 μΐ of the carbonate buffer containing 2 mg/1 of the antibody was added into each well. The strips were covered and incubated overnight at 4 °C. After the incubation period, the antibody solution was aspirated and washed 3 times consecutively with phosphate buffered saline containing 0.5 ml per litre Tween-20 using an ELISA plate washer (a Corning 8 channel washer was used in this work). A solution containing 10 g/1 bovine serum albumin in 250 μΐ aiiquots was dispensed into each well for l h at room temperature to block any unbound sites. Following this period, washing was performed 3 times.
Assay procedure Hundred μΐ of either standard, control or serum that had been diluted 1500-fold were added to the wells. Media samples were added to the wells without diluting: After incubating for 2 h at · phatase or streptavidin-alkaline phosphatase was added to each well for l h at room temperature. After washing, 100 μΐ of the substrate solution was added to each well. The reaction was stopped by the addition of 100 μΐ of 0.3 mol/1 NaOH and the absorbances read at 405 nm using a microplate reader (in this study a Hyperion Micro Reader III, Hyperion Inc. Miami FL, was used). fig. 1) . The concentration of apolipoprotein B was kept constant (1.34 g/1) and the assay carried out as described above. The optimal dilution for the biotinylated antibody was found to be 80-fold when used with ExtrAvidin-alkaline phosphatase and 200-fold when used with streptavidin alkaline phosphatase.
Results

Optimized assay conditions
The dilution of the enzyme conjugate was also optimized for both ExtrAvidin alkaline phosphatase and streptavidin alkaline phosphatase ( fig. 2) . The optimal dilution determined for both enzyme conjugates was 1000-fold.
The final optimization involved determining the optimal substrate incubation time (that which resulted in a standard curve with the highest degree of linearity) for the assay. conditions in which both the antibody-biotin conjugate and the enzyme-conjugates had been optimized. The incubation time of the substrate was varied (5-15 min) using either ExtrAvidin alkaline phosphatase ( fig. 3A) or streptavidin alkaline phosphatase ( fig. 3B ). The optimal incubation time was determined to be 5 min using ExtrAvidin alkaline phosphatase and 7 min using streptavidin alkaline phosphatase. within-run precision (CV), estimated by replicate analysis (n = 10) of an apolipoprotein B control (1.39 g/1) was 3%. The between-run precision of the assay was estimated by measuring the apolipoprotein B control (n = 6) in 9 assays run over a 5-day period. The between-run precision was determined to be 8% at a concentration of 1.39 g/1. The assay was routinely used to measure apolipoprotein B concentrations in HepG2 media under control and hormonal conditions such as insulin and triiodothyronine (19) . Culture media concentrations of 0.16 to 1.80 mg/l were measured directly without having to concentrate the sample. Media samples often required a 2-4-fold dilution. Using media samples, the within-run precision was 5%, based on replicate analysis (n = 5) of two media samples at concentrations of 1.88 and 1.10 mg/l. Accuracy A dilution experiment was conducted in order to estimate the recovery of apolipoprotein B from a dilution series. Such a procedure has been utilized to estimate indirectly the accuray of immunoassays (20) . A plasma-based apolipoprotein B was diluted 1.5 to 12-fold, and apolipoprotein B ELISA was performed on the diluted samples. The mean recovery of apolip oprotein B from the dilution series was 110% (tab. 1).
Comparison with an immunoturbidometric method The sensitivity, based on 2.5 times the standard deviation of the zero standard (n = 5) was determined Results of the assay were compared with those of an to be 3 ng, with a working range of 18 -180 ng. The established immunoturbidometric method on COBAS FARA. Comparison resulted in a correlation of 0.92 with a slope of 1.48 and a y-intercept of -0.04 using sera samples (n = 19) that had been diluted 1500-fold ( fig. 5 ).
Discussion
The use of a non-competitive ELISA for the assay of apolipoprotein B offers several advantages over a number of other assays used to quantitate apolipoprotein B. It does not require that the particle size of the antigen in the standards and samples be comparable as is the case with several immunoprecipitin assays. In addition, our assay is suitable both for media and all types of sera (e. g. dyslipoproteinaetnic sera), since it is not interfered with by turbidity. The assay can also be easily adapted to an automation procedure, unlike radial immunodiffusion and electroimmunoassay techniques. Finally, it avoids the use of radioisotopes, which in a clinical environment poses a number of problems including special training for staff in the handling and disposal of radioactive material.
The precision and sensitivity of the present assay are comparable to the radioimmunoassays used to measure apolipoprotein B (10). In addition, when compared to other ELISAs the current method has a sensitivity and precision comparable to or greater than those assays reported to date (10, 13, 15, 21) . A non-competitive ELISA developed by James et al. (1985) to quantitate apolipoprotein B reported a sensitivity of 2.5 ng per assay with a working range of 10-100 ng. We report a sensitivity of 3 ng per assay with a working range of 18 -180 ng. In addition, the 5 h required to perform this assay is an improvement over several other ELISAs that cannot be easily performed in a normal working day (8, 13, 15) .
The current method compared well with an immunoturbidimetric method on an automated analyzer, but a significant bias was observed between the two methods. This discrepancy in the amount of antigen detected may result from the ELISA procedure; detecting a higher number of antigen molecules present in the sample than that detected by the immunoturbidometric method. Since the sample is diluted considerably in the ELISA method, more antigens may become available for antibody recognition.
The high degree of sensitivity afforded by the use of the biotin-avidin amplification system allows media samples to be assayed directly, without the need for concentrating the samples. The ELISA described here has a sensitivity comparable to that of radioimmunoassay methods commonly used to measure media apolipoprotein B concentrations. In addition, the use of biotinylated antibody avoids the need for conjugating apolipoprotein B antibody to an enzyme. Direct conjugation of antibody to enzymes has a number of drawbacks which are avoided in our assay. The high sensitivity of this assay requires that the standards and sera samples must be diluted considerably in order to be measured. Such high dilution factors have the potential for introducing considerable errors. This does not appear to be a significant problem with our assay as the within-run precision of the assay performed manually was less than 5%. Automating* the dilution of standards and samples should reduce this acceptable imprecision even further.
The assay performed well using either of the two commercial preparations of enzyme-avidin conjugates. However, it was possible to use the streptavidin alkaline phosphatase conjugate with a higher dilution of the biotinylated antibody, resulting in the use of less reagent per assay. The use of streptavidin alkaline phosphatase appeared also to result in standard curves with lower intercepts, suggesting decreased non-specific binding with this reagent. We are cur-rently adapting this non-competitive assay to quantitate other apolipoproteins such as apolipoprotein A-I and E.
